Skip to main content
Erschienen in: Supportive Care in Cancer 1/2022

06.07.2021 | Original Article

Palliative home-based care to pediatric cancer patients: characteristics and healthcare delivered

verfasst von: Íñigo de Noriega, Alberto García-Salido, Ricardo Martino, Blanca Herrero

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Cancer patients constitute an important group in pediatric palliative care. Though the patients’ home is the preferred place of care, little is known about the characteristics of patients attended by units that provide home assistance. Our objective is to describe the characteristics of cancer patients and healthcare delivered by a pediatric palliative care unit with a home hospitalization program.

Methods

Retrospective study based on clinical records of deceased patients attended by the pediatric palliative care unit of Madrid over 10 years. Data collected included general characteristics, type of cancer, whether they received home assistance, place of death, healthcare delivered (hospitalizations, devices, oncological treatments…), and symptom prevalence.

Results

After excluding 47 patients, the clinical records of 144 patients were analyzed. The median age at referral was 9.4 years (IQR: 5.6–14.1), 61.2% were males; 44.2% had solid non-CNS tumors, 35.4% CNS tumors, and 20.4% hematological malignancies; 137 received home care with 89 not requiring further hospital admissions and 70.1% dying at home. The median follow-up time was 1.6 months (IQR: 0.5–2.9). The most used devices were venous ports (71.4%) and oxygen (49.4%); 53.5% of the patients received oncological support therapies. The most common symptoms were pain (91.8%) dyspnea (49.0%) and fatigue (46.9%).

Conclusions

Home assistance was provided in a high number of patients, with a large proportion needing one or no hospital admissions and 70.1% of them dying at home. Further studies characterizing these patients and the factors which promote early access to palliative care are needed.
Literatur
2.
Zurück zum Zitat Zernikow B, Szybalski K, Hübner-Möhler B, Wager J, Paulussen M, Lassay L et al (2019) Specialized pediatric palliative care services for children dying from cancer: a repeated cohort study on the developments of symptom management and quality of care over a 10-year period. Palliat Med 33(3):381–391CrossRef Zernikow B, Szybalski K, Hübner-Möhler B, Wager J, Paulussen M, Lassay L et al (2019) Specialized pediatric palliative care services for children dying from cancer: a repeated cohort study on the developments of symptom management and quality of care over a 10-year period. Palliat Med 33(3):381–391CrossRef
3.
Zurück zum Zitat Snaman JM, Kaye EC, Baker JN, Wolfe J (2018) Pediatric palliative oncology: the state of the science and art of caring for children with cancer. Curr Opin Pediatr 30(1):40–48CrossRef Snaman JM, Kaye EC, Baker JN, Wolfe J (2018) Pediatric palliative oncology: the state of the science and art of caring for children with cancer. Curr Opin Pediatr 30(1):40–48CrossRef
5.
Zurück zum Zitat Friedrichsdorf SJ, Postier A, Dreyfus J, Osenga K, Sencer S, Wolfe J (2015) Improved quality of life at end of life related to home-based palliative care in children with cancer. J Palliat Med 18(2):143–150CrossRef Friedrichsdorf SJ, Postier A, Dreyfus J, Osenga K, Sencer S, Wolfe J (2015) Improved quality of life at end of life related to home-based palliative care in children with cancer. J Palliat Med 18(2):143–150CrossRef
6.
Zurück zum Zitat Coller RJ, Nelson BB, Sklansky DJ, Saenz AA, Klitzner TS, Lerner CF et al (2014) Preventing hospitalizations in children with medical complexity: a systematic review. Pediatrics 134(6):e1628-1647CrossRef Coller RJ, Nelson BB, Sklansky DJ, Saenz AA, Klitzner TS, Lerner CF et al (2014) Preventing hospitalizations in children with medical complexity: a systematic review. Pediatrics 134(6):e1628-1647CrossRef
7.
Zurück zum Zitat Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S et al (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342(5):326–333CrossRef Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S et al (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342(5):326–333CrossRef
8.
Zurück zum Zitat Wolfe J, Orellana L, Ullrich C, Cook EF, Kang TI, Rosenberg A et al (2015) Symptoms and distress in children with advanced cancer: prospective patient-reported outcomes from the PediQUEST study. J Clin Oncol 33(17):1928–1935CrossRef Wolfe J, Orellana L, Ullrich C, Cook EF, Kang TI, Rosenberg A et al (2015) Symptoms and distress in children with advanced cancer: prospective patient-reported outcomes from the PediQUEST study. J Clin Oncol 33(17):1928–1935CrossRef
9.
Zurück zum Zitat Hechler T, Blankenburg M, Friedrichsdorf SJ, Garske D, Hübner B, Menke A et al (2008) Parents’ perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer. Klin Padiatr 220(3):166–174CrossRef Hechler T, Blankenburg M, Friedrichsdorf SJ, Garske D, Hübner B, Menke A et al (2008) Parents’ perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer. Klin Padiatr 220(3):166–174CrossRef
10.
Zurück zum Zitat Goldman A, Hewitt M, Collins GS, Childs M, Hain R, United Kingdom Children’s Cancer Study Group/Paediatric Oncology Nurses’ Forum Palliative Care Working Group (2006) Symptoms in children/young people with progressive malignant disease: United Kingdom Children’s Cancer Study Group/Paediatric Oncology Nurses Forum survey. Pediatrics. 117(6):e1179-1186CrossRef Goldman A, Hewitt M, Collins GS, Childs M, Hain R, United Kingdom Children’s Cancer Study Group/Paediatric Oncology Nurses’ Forum Palliative Care Working Group (2006) Symptoms in children/young people with progressive malignant disease: United Kingdom Children’s Cancer Study Group/Paediatric Oncology Nurses Forum survey. Pediatrics. 117(6):e1179-1186CrossRef
12.
Zurück zum Zitat Craig F, Abu-SaadHuijer H, Benini F, Kuttner L, Wood C, Feraris PC et al (2008) IMPaCCT: standards of paediatric palliative care. Schmerz 22(4):401–408CrossRef Craig F, Abu-SaadHuijer H, Benini F, Kuttner L, Wood C, Feraris PC et al (2008) IMPaCCT: standards of paediatric palliative care. Schmerz 22(4):401–408CrossRef
13.
Zurück zum Zitat Brock KE, Steineck A, Twist CJ (2016) Trends in end-of-life care in pediatric hematology, oncology, and stem cell transplant patients. Pediatr Blood Cancer 63(3):516–522CrossRef Brock KE, Steineck A, Twist CJ (2016) Trends in end-of-life care in pediatric hematology, oncology, and stem cell transplant patients. Pediatr Blood Cancer 63(3):516–522CrossRef
14.
Zurück zum Zitat Kassam A, Skiadaresis J, Alexander S, Wolfe J (2015) Differences in end-of-life communication for children with advanced cancer who were referred to a palliative care team. Pediatr Blood Cancer 62(8):1409–1413CrossRef Kassam A, Skiadaresis J, Alexander S, Wolfe J (2015) Differences in end-of-life communication for children with advanced cancer who were referred to a palliative care team. Pediatr Blood Cancer 62(8):1409–1413CrossRef
15.
Zurück zum Zitat Pritchard M, Burghen E, Srivastava DK, Okuma J, Anderson L, Powell B et al (2008) Cancer-related symptoms most concerning to parents during the last week and last day of their child’s life. Pediatrics 121(5):e1301-1309CrossRef Pritchard M, Burghen E, Srivastava DK, Okuma J, Anderson L, Powell B et al (2008) Cancer-related symptoms most concerning to parents during the last week and last day of their child’s life. Pediatrics 121(5):e1301-1309CrossRef
16.
Zurück zum Zitat Hui D, Didwaniya N, Vidal M, Shin SH, Chisholm G, Roquemore J et al (2014) Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer 120(10):1572–1578CrossRef Hui D, Didwaniya N, Vidal M, Shin SH, Chisholm G, Roquemore J et al (2014) Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer 120(10):1572–1578CrossRef
18.
Zurück zum Zitat Haines ER, Frost AC, Kane HL, Rokoske FS (2018) Barriers to accessing palliative care for pediatric patients with cancer: a review of the literature. Cancer 124(11):2278–2288CrossRef Haines ER, Frost AC, Kane HL, Rokoske FS (2018) Barriers to accessing palliative care for pediatric patients with cancer: a review of the literature. Cancer 124(11):2278–2288CrossRef
20.
Zurück zum Zitat Cherny N, Catane R, Schrijvers D, Kloke M, Strasser F (2010) European Society for Medical Oncology (ESMO) Program for the integration of oncology and Palliative Care: a 5-year review of the Designated Centers’ incentive program. Ann Oncol 21(2):362–369CrossRef Cherny N, Catane R, Schrijvers D, Kloke M, Strasser F (2010) European Society for Medical Oncology (ESMO) Program for the integration of oncology and Palliative Care: a 5-year review of the Designated Centers’ incentive program. Ann Oncol 21(2):362–369CrossRef
21.
Zurück zum Zitat Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30(8):880–887CrossRef Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30(8):880–887CrossRef
23.
Zurück zum Zitat Bluebond-Langner M, Beecham E, Candy B, Langner R, Jones L (2013) Preferred place of death for children and young people with life-limiting and life-threatening conditions: a systematic review of the literature and recommendations for future inquiry and policy. Palliat Med 27(8):705–713CrossRef Bluebond-Langner M, Beecham E, Candy B, Langner R, Jones L (2013) Preferred place of death for children and young people with life-limiting and life-threatening conditions: a systematic review of the literature and recommendations for future inquiry and policy. Palliat Med 27(8):705–713CrossRef
25.
Zurück zum Zitat Weltgesundheitsorganisation (ed) (2012) WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. World Health Organization, Geneva, 166 p Weltgesundheitsorganisation (ed) (2012) WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. World Health Organization, Geneva, 166 p
28.
Zurück zum Zitat Pereira J, Phan T (2004) Management of bleeding in patients with advanced cancer. Oncologist 9(5):561–570CrossRef Pereira J, Phan T (2004) Management of bleeding in patients with advanced cancer. Oncologist 9(5):561–570CrossRef
29.
Zurück zum Zitat Clerici CA, Veneroni L, Giacon B, Mariani L, Fossati-Bellani F (2009) Complementary and alternative medical therapies used by children with cancer treated at an Italian pediatric oncology unit. Pediatr Blood Cancer 53(4):599–604CrossRef Clerici CA, Veneroni L, Giacon B, Mariani L, Fossati-Bellani F (2009) Complementary and alternative medical therapies used by children with cancer treated at an Italian pediatric oncology unit. Pediatr Blood Cancer 53(4):599–604CrossRef
30.
Zurück zum Zitat Cheng L, Wang L, He M, Feng S, Zhu Y, Rodgers C (2018) Perspectives of children, family caregivers, and health professionals about pediatric oncology symptoms: a systematic review. Support Care Cancer 26(9):2957–2971CrossRef Cheng L, Wang L, He M, Feng S, Zhu Y, Rodgers C (2018) Perspectives of children, family caregivers, and health professionals about pediatric oncology symptoms: a systematic review. Support Care Cancer 26(9):2957–2971CrossRef
31.
Zurück zum Zitat Collins JJ, Byrnes ME, Dunkel IJ, Lapin J, Nadel T, Thaler HT et al (2000) The measurement of symptoms in children with cancer. J Pain Symptom Manage 19(5):363–377CrossRef Collins JJ, Byrnes ME, Dunkel IJ, Lapin J, Nadel T, Thaler HT et al (2000) The measurement of symptoms in children with cancer. J Pain Symptom Manage 19(5):363–377CrossRef
32.
Zurück zum Zitat Madden K, MagnoCharone M, Mills S, Dibaj S, Williams JL, Liu D et al (2019) Systematic symptom reporting by pediatric palliative care patients with cancer: a preliminary report. J Palliat Med 22(8):894–901CrossRef Madden K, MagnoCharone M, Mills S, Dibaj S, Williams JL, Liu D et al (2019) Systematic symptom reporting by pediatric palliative care patients with cancer: a preliminary report. J Palliat Med 22(8):894–901CrossRef
33.
Zurück zum Zitat Collins JJ, Devine TD, Dick GS, Johnson EA, Kilham HA, Pinkerton CR et al (2002) The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7–12. J Pain Symptom Manage 23(1):10–16CrossRef Collins JJ, Devine TD, Dick GS, Johnson EA, Kilham HA, Pinkerton CR et al (2002) The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7–12. J Pain Symptom Manage 23(1):10–16CrossRef
34.
Zurück zum Zitat Snaman JM, Baker JN, Ehrentraut JH, Anghelescu DL (2016) Pediatric oncology: managing pain at the end of life. Paediatr Drugs 18(3):161–180CrossRef Snaman JM, Baker JN, Ehrentraut JH, Anghelescu DL (2016) Pediatric oncology: managing pain at the end of life. Paediatr Drugs 18(3):161–180CrossRef
Metadaten
Titel
Palliative home-based care to pediatric cancer patients: characteristics and healthcare delivered
verfasst von
Íñigo de Noriega
Alberto García-Salido
Ricardo Martino
Blanca Herrero
Publikationsdatum
06.07.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2022
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06412-5

Weitere Artikel der Ausgabe 1/2022

Supportive Care in Cancer 1/2022 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.